Jeffrey R Stokes
Affiliation: Creighton University
- The use of anti-IgE therapy beyond allergic asthmaJeffrey R Stokes
Division of Allergy Immunology, Creighton University, Omaha, Neb Electronic address
J Allergy Clin Immunol Pract 3:162-6. 2015..More carefully designed, large clinical trials of high quality are needed to fully appreciate the potential of omalizumab in treating various allergic and nonallergic diseases. ..
- Promising future therapies for asthmaJeffrey R Stokes
Division of Allergy and Immunology, Creighton University Medical Center, 601 N 30th St, Suite 3M 100, Omaha, NE 68131, United States Electronic address
Int Immunopharmacol 23:373-7. 2014..In eosinophilic asthma blocking IL-4, IL-5 and IL-13 have improved asthma outcomes. The promise of more directed therapy for asthma appears closer than ever with increased options available for the clinician in the near future...
- Allergy immunotherapy for primary care physiciansJeffrey R Stokes
Creighton University, Division of Allergy Immunology, Department of Medicine, Omaha, Neb 68131, USA
Am J Med 119:820-3. 2006..Even with newer therapies on the horizon, allergen immunotherapy will continue to have an important role in the treatment of allergic diseases...
- Future forms of immunotherapy and immunomodulators in allergic diseaseTran Hoai T Nguyen
Department of Medicine, Division of Allergy and Immunology, Creighton University School of Medicine, 601 North 30th Street, Suite 3M100, Omaha, NE 68131, USA
Immunol Allergy Clin North Am 31:343-65, x-xi. 2011..The goals of these therapies are to improve patient symptoms and quality of life, to prevent and favorably alter disease course, and to maintain a good risk/benefit ratio along with a cost-effective profile...
- Allergic rhinitis and asthma: celebrating 100 years of immunotherapyJeffrey R Stokes
Creighton University School Medicine, Department of Medicine, Allergy Immunology Division, Omaha, NE 68131, United States
Curr Opin Immunol 23:808-13. 2011..Here we review the top 50 articles published in the past 2 years on allergens, environmental control, and immunotherapy for asthma and allergic rhinitis and the use of immunomodulators in allergic disease...
- Future forms of immunotherapyThomas B Casale
Division of Allergy Immunology, Creighton University, Omaha, Neb 68131, USA
J Allergy Clin Immunol 127:8-15; quiz 16-7. 2011..One thing is clear: the next century of immunotherapy will be vastly different from today's current standard of care...
- Characterization of asthma endotypes: implications for therapyJeffrey R Stokes
Division of Allergy and Immunology, Creighton University, Omaha, Nebraska
Ann Allergy Asthma Immunol 117:121-5. 2016..To describe the concept of precision medicine in treating severe asthma and the utility of relevant biomarkers...
- Anti-immunoglobulin e therapyManav Segal
From the Division of Allergy and Immunology, Department of Medicine, Creighton University School of Medicine, Omaha, NE
World Allergy Organ J 1:174-83. 2008..Considerations regarding dosing and safety of omalizumab will be addressed as well...
- The effects of an H3 receptor antagonist (PF-03654746) with fexofenadine on reducing allergic rhinitis symptomsJeffrey R Stokes
Department of Medicine, Division of Allergy Immunology, Creighton University School Medicine, Omaha, Neb 68131, USA
J Allergy Clin Immunol 129:409-12, 412.e1-2. 2012..Nasal H(3) receptors might have a role in mediating the effects of histamine in patients with allergic rhinitis...
- Immunomodulators for allergic respiratory disordersThomas B Casale
Department of Medicine, Division of Allergy Immunology, Creighton University, Omaha, NE 68131, USA
J Allergy Clin Immunol 121:288-96; quiz 297-8. 2008..The goal of this review is to summarize the data from human clinical trials with immunomodulators, discussing the rationale for their use, efficacy results, and putative adverse events associated with them...